Home › Funds › CANNELL CAPITAL LLC › VRCA
CANNELL CAPITAL LLC position in VRCA
VERRICA PHARMACEUTICALS INC · Health Care
CANNELL CAPITAL LLC reported holding 693,552 shares of VRCA (VERRICA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$3.3M, representing 2.94% of its reported portfolio and ranking #17 among its reported holdings. CANNELL CAPITAL LLC has disclosed VRCA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How CANNELL CAPITAL LLC's VRCA position evolved
CANNELL CAPITAL LLC first disclosed a stake in VRCA in Q1 2026 at 685,123 shares (US$3.6M). The position peaked in Q2 2026 at 783,923 shares, worth US$4.8M. Across 3 filings, CANNELL CAPITAL LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 693,552 shares valued at US$3.3M — a reduction of -90,371 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 685.12K | $3.62M | New |
| Q2 2026 | 783.92K | $4.80M | Add |
| Q3 2026 | 693.55K | $3.33M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VRCA and 13F data
VRCA (VERRICA PHARMACEUTICALS INC) is a Health Care company. 19 other funds we track also report a position in VRCA — the largest reported positions include Caligan Partners LP (US$4.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on CANNELL CAPITAL LLC
FAQ
How long has CANNELL CAPITAL LLC held VRCA?
CANNELL CAPITAL LLC has disclosed VRCA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is CANNELL CAPITAL LLC's current position in VRCA?
As of Q3 2026, CANNELL CAPITAL LLC holds 693.55K shares of VRCA (VERRICA PHARMACEUTICALS INC), valued at $3.33M, representing 2.94% of its reported portfolio and ranking #17.
Has CANNELL CAPITAL LLC been buying or selling VRCA?
In the latest 13F filing (Q3 2026), CANNELL CAPITAL LLC reduced its position in VRCA. The position peaked in Q2 2026 at 783.92K shares.
Which other funds hold VRCA?
Other major institutional holders of VRCA include Caligan Partners LP, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.